- Home
- STG vs INCR Comparison
STG vs INCR Comparison
Compare STG & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STG
- INCR
- Stock Information
- Founded
- STG 2003
- INCR 1994
- Country
- STG China
- INCR Israel
- Employees
- STG N/A
- INCR N/A
- Industry
- STG Other Consumer Services
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- STG Real Estate
- INCR Health Care
- Exchange
- STG Nasdaq
- INCR Nasdaq
- Market Cap
- STG 91.6M
- INCR 76.7M
- IPO Year
- STG 2018
- INCR N/A
- Fundamental
- Price
- STG $5.89
- INCR $1.70
- Analyst Decision
- STG
- INCR
- Analyst Count
- STG 0
- INCR 0
- Target Price
- STG N/A
- INCR N/A
- AVG Volume (30 Days)
- STG 9.4K
- INCR 43.9K
- Earning Date
- STG 11-22-2024
- INCR 02-15-2025
- Dividend Yield
- STG N/A
- INCR N/A
- EPS Growth
- STG N/A
- INCR N/A
- EPS
- STG 4.57
- INCR N/A
- Revenue
- STG $292,030,936.00
- INCR $72,420,918.00
- Revenue This Year
- STG N/A
- INCR N/A
- Revenue Next Year
- STG N/A
- INCR $39.30
- P/E Ratio
- STG $1.29
- INCR N/A
- Revenue Growth
- STG N/A
- INCR N/A
- 52 Week Low
- STG $4.25
- INCR $1.17
- 52 Week High
- STG $12.55
- INCR $3.72
- Technical
- Relative Strength Index (RSI)
- STG 49.83
- INCR 57.80
- Support Level
- STG $5.50
- INCR $1.63
- Resistance Level
- STG $5.79
- INCR $1.75
- Average True Range (ATR)
- STG 0.30
- INCR 0.07
- MACD
- STG 0.03
- INCR 0.01
- Stochastic Oscillator
- STG 65.83
- INCR 64.57
About STG Sunlands Technology Group
Sunlands Technology Group is a provider of online post-secondary and professional education services in China. The company offers various degree- and diploma-oriented post-secondary courses through its online platforms. In addition, it provides online professional courses and educational content to help students prepare for professional certification exams and attain professional skills. The Group has one operating segment, which is the provision of online education services.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.